Gray matter alterations are typical features of brain disorders. However, they do not impact on the brain randomly. Indeed, it has been suggested that neuropathological processes can selectively affect certain assemblies of neurons, which typically are at the center of crucial functional networks. Because of their topological centrality, these areas form a core set that is more likely to be affected by neuropathological processes. In order to identify and study the pattern formed by brain alterations in patients’ with Alzheimer’s disease (AD), we devised an innovative meta-analytic method for analyzing voxel-based morphometry data. This methodology enabled us to discover that in AD gray matter alterations do not occur randomly across the br...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is associated not only with regional gray matter damages, but also with abn...
Introduction Understanding disease progression in Alzheimer’s disease (AD) awaits the resolution o...
Elucidating distinct morphological atrophy patterns of Alzheimer’s disease (AD) and its prodromal st...
Brains suffering from Alzheimer’s disease show pronounced morphological modifications, with ample vo...
Brains suffering from Alzheimer’s disease show pronounced morphological modifications, with ample vo...
Background. We aimed to investigate how altered intrinsic connectivity networks (ICNs) affect pathol...
Clinical symptoms observed in Alzheimer's disease (AD) patients may reflect variations within specif...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is one of the most common forms of dementia that has slowly negative impact...
Alzheimer’s disease (AD) is associated not only with regional gray matter damages, but also with abn...
Introduction Understanding disease progression in Alzheimer’s disease (AD) awaits the resolution o...
Elucidating distinct morphological atrophy patterns of Alzheimer’s disease (AD) and its prodromal st...
Brains suffering from Alzheimer’s disease show pronounced morphological modifications, with ample vo...
Brains suffering from Alzheimer’s disease show pronounced morphological modifications, with ample vo...
Background. We aimed to investigate how altered intrinsic connectivity networks (ICNs) affect pathol...
Clinical symptoms observed in Alzheimer's disease (AD) patients may reflect variations within specif...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...
The increasing prevalence of Alzheimer's disease (AD) emphasizes the need for sensitive biomarkers. ...